[F1] Flash Talks (Odd No.)

1:47 PM - 1:48 PM JST(4:47 AM - 4:48 AM UTC)

[F-35] Development of IL-12-expressing HSV-1 for malignant melanoma

*Hitomi Nakamura^1,2, Miwako Iwai¹, Ryuhei Okuyama², Tomoki Todo¹ (1. Project Division of Oncolytic Virus Development, The Institute of Medical Science, The University of Tokyo (Japan), 2. The Department of Dermatology, Shinshu University School of Medicine (Japan))

Keywords:

Oncolytic virus therapy,Herpes simplex virus type 1 (HSV-1),Interleukin 12 (IL-12),Malignant melanoma,In situ cancer vaccine

Password required to view

Log in

or